Our Chronic Pain Clinical Trials

pain2


Our Chronic Pain Clinical Trials

“Pain is a more terrible lord of mankind than even death itself,” is what the legendary physician and philosopher Dr. Albert Schweitzer wrote in 1953—and it’s especially true for chronic pain. Nearly 10% of the U.S. population is affected by chronic pain, whether it’s headaches, back, joint, or nerve pain, irritable bowel, or fibromyalgia. In addition, 10% of the U.S. population categorize their pain—chronic or otherwise—as severe.

Both over-the-counter and prescription medications currently available to those who suffer from chronic pain are in fact better suited for acute pain. These medications were not developed to be taken long term. When aspirin, ibuprofen, and naproxen, among other anti-inflammatory medications are taken long term, they can lead to a variety of stomach issues, as well as kidney and cardiovascular disease.

Opioids—narcotic pain medications—present an entirely different set of issues, much worse in many cases. Although opioids are initially strong and effective, the body develops a tolerance over time so they don’t actually treat chronic pain all that well. Opioids are also highly addictive, can cause drowsiness, sleepiness, nausea, and constipation, among other symptoms.

Despite the fairly common condition of chronic pain, medication options are limited; it’s an area in desperate need of drug development. Through our specialized clinical trials, MedVadis Research is helping to create medications that effectively and safely treat pain with limited, to no side effects. Our studies are ongoing and we encourage interested volunteers to inquire.

Current Chronic Pain Clinical Trials